Top Markets
Coin of the day
China Biotech Services Holdings Limited China Biotech Services Holdings Limited

China Biotech Services Holdings Limited

8037
주식 순위 #23175
Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech... Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throughout mainland China and Hong Kong. The company organizes its varied operations into five main divisions: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, and Insurance Brokerage, in addition to other undertakings. Its comprehensive activities include the research, development, manufacturing, and sale of both health-related and pharmaceutical products. The company also offers specialized medical services, such as tumor immune cell therapy, immune cell storage, and health management programs, alongside coordinating healthcare providers. Furthermore, it participates in financial services like securities trading, money lending, and providing insurance brokerage. Its commercial ventures also extend to marketing and distributing a range of wellness products, including health supplements, slimming aids, traditional Chinese medicines, and beauty products, as well as trading pharmaceutical intermediates. Property investment and logistics services round out its operational scope. The company transitioned to its current name in November 2017, having previously been known as Rui Kang Pharmaceutical Group Investments Limited.
주가
$0.07931426
마지막 동기화: 2026-08-21
시가총액
$77.39M
변동 (1일)
0.81%
변동 (1년)
-49.20%
국가
HK
거래 China Biotech Services Holdings Limited (8037)

카테고리

China Biotech Services Holdings Limited (8037)의 주식 분할 이력
China Biotech Services Holdings Limited 주식 (심볼: 8037)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 22, 2026에 발생했습니다.
Aug 22, 2026 이전에 매수한 8037 주식 1주는 현재 0주의 8037 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할